ACACB and breast cancer: Another significant gene, acetyl-CoA carboxylase beta (ACACB), which is crucial for fatty acid oxidation and is downregulated in BC, is associated with increased survival and reduced drug resistance, highlighting its potential as a target for inhibiting tumor cell proliferation and metabolic reprogramming [59].